Deep Currents Investment Group LLC has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $51 Million distributed in 288 stocks.
Among their holdings, we can observe that their the top five positions include companies like: News Corp with a value of $10.2M, Jazz Pharmaceuticals PLC with a value of $9.27M, At&T Inc. with a value of $6.65M, Western Digital Corp with a value of $5.18M, and Global Payments Inc with a value of $2.9M.
Examining the 13F form we can see an decrease of $36.7M in the current position value, from $87.7M to 51M .
Deep Currents Investment Group LLC is based out at New York, NY
Below you can find more details about Deep Currents Investment Group LLC portfolio as well as his latest detailed transactions.
Portfolio value
$51 Million
Communication Services: $17.6 Million
Healthcare: $11.8 Million
Technology: $7.78 Million
Industrials: $6.39 Million
ETFs: $5.49 Million
Financial Services: $1.19 Million
Consumer Cyclical: $397,000
Energy: $355,000
Other: $81,000
Stock
Market Cap.
Holding Value (Reported)
# of Shares.
Last Trade
Trade History
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 20.76%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 52.81%
-
$0
0.0% of portfolio
-
Q3 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
Added 21.43%
-
$0
0.0% of portfolio
-
Q3 2024
Added 50.26%
-
$0
0.0% of portfolio
-
Q3 2025
Added 35.44%
-
$0
0.0% of portfolio
-
Q3 2025
Added 114.72%
-
$0
0.0% of portfolio
-
Q3 2025
Added 289.66%
-
$0
0.0% of portfolio
-
Q1 2024
Added 11.92%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 66.67%
-
$0
0.0% of portfolio
-
Q1 2023
Added 48.37%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 36.2%
-
$0
0.0% of portfolio
-
Q3 2025
Added 109.75%
-
$0
0.0% of portfolio
-
Q3 2025
New
-
$0
0.0% of portfolio
-
Q3 2025
Added 4.3%
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 26.95%
-
$0
0.0% of portfolio
-
Q3 2025
Added 82.28%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 37.17%
-
$0
0.0% of portfolio
-
Q3 2025
Added 78.19%
-
$0
0.0% of portfolio
-
Q3 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
Added 19.71%
-
$0
0.0% of portfolio
-
Q3 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 91.46%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 83.75%
Apellis Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 0.67%
-
$0
0.0% of portfolio
-
Q3 2025
Added 85.75%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 47.84%
-
$0
0.0% of portfolio
-
Q3 2025
New
-
$0
0.0% of portfolio
-
Q3 2025
New
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 12.7%
-
$0
0.0% of portfolio
-
Q3 2024
Added 113.04%
-
$0
0.0% of portfolio
-
Q3 2025
New
-
$0
0.0% of portfolio
-
Q3 2025
Added 3.1%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 16.61%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 6.7%
-
$0
0.0% of portfolio
-
Q3 2025
Added 166.51%
-
$0
0.0% of portfolio
-
Q1 2025
Added 9.56%
-
$0
0.0% of portfolio
-
Q3 2025
Added 27.69%
Halozyme Therapeutics Inc
-
$0
0.0% of portfolio
-
Q3 2025
New
-
$0
0.0% of portfolio
-
Q3 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 19.05%
-
$0
0.0% of portfolio
-
Q1 2025
New
Ionis Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q3 2025
Added 16.55%
-
$0
0.0% of portfolio
-
Q1 2025
Added 19.09%
-
$0
0.0% of portfolio
-
Q3 2025
Added 9.94%
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Added 13.33%
-
$0
0.0% of portfolio
-
Q3 2025
Added 99.06%
-
$0
0.0% of portfolio
-
Q3 2025
New